BCTXZ Stock Summary and Trading Ideas (Briacell Therapeutics Corp. - Warrant | NASDAQ:BCTXZ)

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

What symbol and exchange does Briacell Therapeutics Corp. - Warrant shares trade?

Briacell Therapeutics Corp. - Warrant trades on the NASDAQ stock market under the symbol BCTXZ.

What is Briacell Therapeutics Corp. - Warrant stock price doing today?

As of January 21, 2026, BCTXZ stock price declined to $0.17 with 10,287 million shares trading.

How much is Briacell Therapeutics Corp. - Warrant worth?

BCTXZ has a market cap of $0.00. This is considered a Sub-Micro Cap stock.

What are the support and resistance levels for Briacell Therapeutics Corp. - Warrant (BCTXZ)?

BCTXZ support price is $.16 and resistance is $.26 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BCTXZ shares will trade within this expected range on the day.